Order Article Reprints

Alarfaj RE, Alkhulaifi MM, Al-Fahad AJ, Aljihani S, Yassin AEB, Alghoribi MF, Halwani MA. Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii. Pharmaceutics. 2022; 14(1):130. https://doi.org/10.3390/pharmaceutics14010130

Alarfaj, Reem E., Manal M. Alkhulaifi, Ahmed J. Al-Fahad, Shokran Aljihani, Alaa Eldeen B. Yassin, Majed F. Alghoribi, and Majed A. Halwani. 2022. "Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii" Pharmaceutics 14, no. 1: 130. https://doi.org/10.3390/pharmaceutics14010130

Alarfaj, R. E., Alkhulaifi, M. M., Al-Fahad, A. J., Aljihani, S., Yassin, A. E. B., Alghoribi, M. F., & Halwani, M. A. (2022). Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii. Pharmaceutics, 14(1), 130. https://doi.org/10.3390/pharmaceutics14010130